Post-stroke cognitive impairment
Conditions
Interventions
Control group:According to the requirements of the "Chinese Guidelines for the Primary Prevention and Treatment of Cerebrovascular Disease 2019" and the requirements of the stroke unit, strictly contr
It can also perform various calculations of numbers, size comparison, and other training. (5) Executive function training: including arranging designated numbers, origami, simulating shopping, learnin
Treatment group:According to the requirements of the "Chinese Guidelines for the Primary Prevention and Treatment of Cerebrovascular Disease 2019" and the requirements of the stroke unit, strictly con
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the diagnostic criteria for post-stroke cognitive impairment; (2) Age 40-75 years old, gender and education are not limited; (3) First onset, the course of the disease is 2 weeks to 6 months; (4) The condition is stable, the mind is clear, and the compliance is good; (5) Montreal Cognitive Assessment Scale (MoCA) score <26; (6) Informed and voluntary participation in this clinical trial, and the informed consent form for the clinical trial shall be signed by the person or his guardian.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cognitive impairment with a MoCA score of Hamilton or Hamilton Patients with severe anxiety with a score of > 28 on the Erton Anxiety Scale (HAMA); (3) Those who have cognitive impairment, depression, anxiety, and sleep disorders before the stroke event; (4) Cognitive impairment caused by congenital developmental abnormalities, or cognitive impairment caused by other diseases (such as Alzheimer's disease, traumatic brain injury, etc.); (5) Those who have other serious heart, liver, brain, kidney, digestive system, circulatory system and other diseases, or have serious systemic infections and tumors; (6) Those with severe mental illness, metabolic disease, or visual and auditory impairment; (7) Those who have taken drugs to improve cognitive impairment, anxiety, depression, and sleep disorders in the past 3 months or have received treatment in this area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Montreal cognitive assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale;Hamilton Anxiety Scale;Pittsburgh sleep quality index;Barthel index; | — |
Countries
China
Contacts
Public ContactJinxia Ni
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed